文献速递外周动脉疾病

慢性肢体威胁性缺血患者行腹股沟下外科或腔内血运重建后步行状态变化对生存的影响

Impact of ambulatory status change on survival in patients with chronic limb-threatening ischemia undergoing infrainguinal surgical or endovascular revascularization.
PubMed 文献 · J Vasc Surg · 2023-03-16

该回顾性多中心研究分析2015至2020年间因慢性肢体威胁性缺血(CLTI)行腹股沟下旁路手术或腔内治疗(EVT)的377例患者508条肢体,发现术前不能行走者术后恢复行走与更好的总生存相关,术前不能行走者术后并发症风险较高,但无低体重指数和脑血管病等因素者可能从血运重建中获益。

要点

  • 术前能行走且术后仍能行走者1年总生存率为86.8%,术前不能行走且术后仍不能行走者为54.7%。
  • 术前不能行走者术后并发症发生率为31.0%,术前能行走者为17.0%(P < .01)。
  • 术前不能行走者中,体重指数增加(P < .01)和无脑血管病(P = .04)与步行状态改善独立相关。

核心结论

  • 术前不能行走的CLTI患者行腹股沟下血运重建后,步行状态改善与更好的总生存相关。
  • 术前不能行走者存在术后并发症风险,但无低体重指数和脑血管病等因素者可能从血运重建中获益并改善步行状态。

研究设计与样本

  • 回顾性分析两个血管中心2015至2020年间因CLTI行腹股沟下旁路手术或EVT的患者数据。
  • 共分析377例患者和508条肢体,主要终点为总生存,次要终点为步行状态变化和术后并发症。

主要发现

  • 根据血运重建前后步行状态变化,1年总生存率在能行走→能行走组为86.8%,不能行走→能行走组为81.1%,不能行走→不能行走组为54.7%,能行走→不能行走组为23.9%(P < .01)。
  • 术前不能行走队列中,术后不能行走组平均体重指数低于术后能行走组(P < .01),脑血管病比例高于术后能行走组(P = .01)。
  • 术前能行走队列中,术后不能行走组平均CONUT评分高于术后能行走组(P < .01)。
  • 术前不能行走者中,体重指数增加(P < .01)和无脑血管病(P = .04)是与步行状态改善独立相关的因素。
  • 术前能行走者中,年龄增加(P = .04)、WIfI分期较高(P = .02)和CONUT评分增加(P < .01)是步行状态下降的独立危险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the influence of change in ambulatory status on the prognosis of patients with chronic limb-threatening ischemia (CLTI) undergoing infrainguinal bypass surgery or endovascular therapy (EVT). METHODS: We retrospectively analyzed data from two vascular centers for patients who underwent revascularization for CLTI between 2015 and 2020. The primary endpoint was overall survival (OS), and the secondary endpoints were changes in ambulatory status and postoperative complications. RESULTS: Throughout the study, 377 patients and 508 limbs were analyzed. In the preoperative nonambulation cohort, the average body mass index (BMI) was lower in the postoperative nonambulatory group than in the postoperative ambulatory group (P < .01). The percentage of cerebrovascular disease (CVD) was higher in the postoperative nonambulatory group than in the postoperative ambulatory group (P = .01). In the preoperative ambulation cohort, the average controlling nutritional status (CONUT) score was higher in the postoperative nonambulatory group than in the postoperative ambulatory group (P < .01). There was no difference in the bypass percentage and the EVT in the preoperative nonambulation (P = .32) and ambulation (P = .70) cohorts. According to the change in ambulatory status before and after revascularization, the 1-year OS rates were 86.8% in the ambulatory → ambulatory group, 81.1% in the nonambulatory → ambulatory group, 54.7% in the nonambulatory → nonambulatory group, and 23.9% in the ambulatory → nonambulatory group (P < .01). On multivariate analysis, increased age (P = .04), higher Wound, Ischemia, and foot Infection stage (P = .02), and increased CONUT score (P < .01) were independent risk factors for the decline in ambulatory status in patients with preoperative ambulation. In patients with preoperative nonambulation, increased BMI (P < .01) and absence of CVD (P = .04) were independent factors related to the improved ambulatory status. The percentages of postoperative complications were 31.0% and 17.0% in the preoperative nonambulation and the preoperative ambulation in the overall cohort (P < .01). Preoperative nonambulatory status (P < .01), CONUT score (P < .01), and bypass surgery (P < .01) were risk factors for postoperative complications. CONCLUSIONS: Improved ambulatory status is associated with better OS in patients with preoperative nonambulatory status after infrainguinal revascularization for CLTI. Although patients with preoperative nonambulatory status have a risk of postoperative complication, some may benefit from revascularization if they have no factors such as low BMI and CVD, improving their ambulatory status.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Morisaki K, Guntani A, Kinoshita G, et al. Impact of ambulatory status change on survival in patients with chronic limb-threatening ischemia undergoing infrainguinal surgical or endovascular revascularization. J Vasc Surg. 2023. PMID: 36933751. doi:10.1016/j.jvs.2023.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。